Compare Alnylam Pharmaceuticals, Inc. (ALNY) vs The Vita Coco Company Inc (COCO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alnylam Pharmaceuticals, Inc. vs The Vita Coco Company Inc — how do they compare? Alnylam Pharmaceuticals, Inc. trades at $221.5 (market cap $29.60B), while The Vita Coco Company Inc trades at $64.43 (market cap $3.73B). The key difference: Alnylam Pharmaceuticals, Inc. is far larger — about 7.9× The Vita Coco Company Inc's market cap, and The Vita Coco Company Inc is trading nearer its 52-week high, Alnylam Pharmaceuticals, Inc. nearer its low. Which is the better fit depends on your goals.
| ALNY | COCO | |
|---|---|---|
Market Cap | $29.60B | $3.73B |
Sector | Health | Technology |
52-Week High | $491.22 | $84.02 |
52-Week Low | $205.48 | $32.37 |
Enterprise Value | $27.56B | $3.47B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia.
Read more on ALNY →About The Vita Coco Company Inc
The Vita Coco Company is a leading functional beverage brand specializing in coconut water. Its portfolio includes its flagship Vita Coco brand, clean energy drinks, and sustainable enhanced water products.
Read more on COCO →
